Hemo-metabolic impairment in patients with ST-segment elevation myocardial infarction: Data from the INTERSTELLAR registry.
Min Gyu KongJon SuhBora LeeHyun Woo ParkSu Yeong ParkInki MoonHyung Oh ChoiHye-Sun SeoYoon Haeng ChoNae-Hee LeeHo-Jun JangTae-Hoon KimSung Woo KwonSang-Don ParkPyung Chun OhJeonggeun MoonKyounghoon LeeWoong Chol KangPublished in: Cardiology journal (2023)
Hemo-metabolic impairment is significantly associated with increased risk of in-hospital and 1-year mortality in patients with STEMI. It remains a significant prognostic factor, regardless of DTB time.
Keyphrases
- st segment elevation myocardial infarction
- prognostic factors
- percutaneous coronary intervention
- st elevation myocardial infarction
- coronary artery disease
- acute coronary syndrome
- cardiovascular events
- healthcare
- electronic health record
- risk factors
- emergency department
- type diabetes
- big data
- acute care
- adverse drug
- machine learning
- artificial intelligence